1,2-distearoylphosphatidylethanolamine has been researched along with carbocyanines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fahr, A; Hilger, I; Kontermann, RE; Rabenhold, M; RĂ¼ger, R; Steiniger, F; Tansi, FL | 1 |
Fumoto, S; Kawakami, S; Kuroda, N; Miyamoto, H; Nishida, K; Peng, JQ; Suga, T | 1 |
2 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and carbocyanines
Article | Year |
---|---|
In vivo near-infrared fluorescence imaging of FAP-expressing tumors with activatable FAP-targeted, single-chain Fv-immunoliposomes.
Topics: Animals; Carbocyanines; Cell Line, Tumor; Cells, Cultured; Endopeptidases; Female; Fluorescent Dyes; Gelatinases; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Liposomes; Maleimides; Membrane Proteins; Mice, Nude; Neoplasms; Optical Imaging; Phosphatidylethanolamines; Polyethylene Glycols; Serine Endopeptidases; Single-Chain Antibodies; Spectroscopy, Near-Infrared | 2014 |
Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles.
Topics: Animals; Antineoplastic Agents; Calcium Carbonate; Carbocyanines; Cell Line, Tumor; Cell Membrane Permeability; Drug Liberation; Drug Therapy, Combination; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Lipids; Male; Mice; Molecular Targeted Therapy; Nanocapsules; Neoplasms, Experimental; Oligopeptides; Optical Imaging; Paclitaxel; Phosphatidylethanolamines; Serum Albumin, Bovine; Superoxide Dismutase; Surface Properties | 2019 |